Hester Biosciences Limited (NSE:HESTERBIO)

Hester Biosciences Revenue

In the fiscal year ending March 31, 2026, Hester Biosciences had annual revenue of 3.34B INR with 6.93% growth. Hester Biosciences had revenue of 1.02B in the quarter ending March 31, 2026, with 40.33% growth.

• Revenue: 3.34B
• Revenue Growth: +6.93%
• P/S Ratio: 6.18
• Revenue / Employee: 6.92M
• Employees: 483
• Market Cap: 20.67B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	3.34B	216.47M	6.93%
Mar 31, 2025	3.12B	12.80M	0.41%
Mar 31, 2024	3.11B	329.89M	11.86%
Mar 31, 2023	2.78B	315.58M	12.79%
Mar 31, 2022	2.47B	289.51M	13.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error